Skip to main content

Want a detailed portfolio tracker?

PMV Pharmaceuticals (PMVP) P/E (2020 - 2026)

PMV Pharmaceuticals (PMVP) P/E from Sep 25, 2020 to Jun 3, 2026. The TTM PMV Pharmaceuticals (PMVP) P/E is -0.79. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PMV Pharmaceuticals (PMVP)

YearP/EChange
2026-0.79-7.36%
2025-0.85-36.17%
2024-1.33-33.74%
2023-2.01-63.35%
2022-5.48-69.68%
2021-18.07-74.48%
2020-70.82N/A

Comparison PMV Pharmaceuticals (PMVP) P/E with competitors

PMV Pharmaceuticals (PMVP) P/E is -0.79.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.22%
NBYStablecoin Development Corp0.10-112.99%
ENLVEnlivex Therapeutics Ltd0.15-119.09%
FGENFibroGen Inc0.24-130.50%
TRAWTraws Pharma Inc0.47-160.09%
FBIOFortress Biotech Inc0.71-189.72%
CHRSCoherus Biosciences Inc0.98-224.30%
ORMPOramed Pharmaceuticals Inc1.47-287.24%
AGENAgenus Inc2.05-360.32%
VIVSVivoSim Labs Inc2.54-422.25%
INVAInnoviva Inc3.19-505.19%
CRMDCorMedix Inc3.65-563.30%
ABEOAbeona Therapeutics Inc4.20-634.37%
VXRTVaxart Inc4.26-641.57%
CVACCureVac N.V.4.45-664.95%
SRPTSarepta Therapeutics Inc4.62-687.65%
GLPGGalapagos NV4.86-717.46%
RIGLRigel Pharmaceuticals4.92-725.17%
ZVRAZevra Therapeutics Inc4.97-732.10%
ABUSArbutus Biopharma Corp5.69-823.56%
CGENCompugen Ltd7.38-1038.36%
AUPHAurinia Pharmaceuticals Inc9.25-1275.69%
ACADAcadia Pharmaceuticals Inc9.59-1318.46%
OMEROmeros Corporation9.88-1356.00%
SPROSpero Therapeutics Inc10.73-1464.19%
ADMAAdma Biologics Inc11.33-1539.92%
SVASinovac Biotech Ltd11.44-1553.31%
TBPHTheravance Biopharma Inc11.78-1596.60%
HRMYHarmony Biosciences Holdings Inc12.18-1647.92%
TGTXTG Therapeutics Inc13.18-1774.87%
INCYIncyte Corp13.38-1800.62%
SABSSAB Biotherapeutics Inc14.06-1886.49%
XOMAXOMA Corp14.95-1999.28%
REGNRegeneron Pharmaceuticals Inc14.98-2003.72%
PBYIPuma Biotechnology Inc15.05-2012.65%
EXELExelixis Inc15.79-2107.25%
NAGENiagen Bioscience Inc16.35-2178.43%
CPRXCatalyst Pharmaceuticals Inc17.34-2304.21%
MDXGMimedx Group Inc17.38-2308.10%
ARGXArgen X SE23.07-3031.99%
HALOHalozyme Therapeutics Inc23.20-3048.39%
XOMAOXOMA Corp25.34-3320.88%
VRTXVertex Pharmaceuticals Inc25.66-3360.40%
XOMAPXOMA Corp25.67-3362.22%
CTMXCytomX Therapeutics Inc25.70-3365.75%
ASNDAscendis Pharma A/S26.35-3449.15%
RPRXRoyalty Pharma plc - Class A27.50-3594.19%
SLNOSoleno Therapeutics Inc29.02-3787.34%
LGNDLigand Pharmaceuticals Inc - Class B30.19-3936.18%
BMRNBiomarin Pharmaceutical Inc37.51-4866.52%
APLSApellis Pharmaceuticals Inc39.02-5058.91%
KRYSKrystal Biotech Inc39.70-5144.87%
GMABGenmab40.20-5209.18%
ONCBeiGene Ltd67.03-8617.96%
TECHBio-Techne Corp68.59-8817.24%
VCELVericel Corp80.63-10346.58%
PHARPharming Group N.V.87.74-11250.26%
ALNYAlnylam Pharmaceuticals Inc124.93-15976.91%
TLXTelix Pharmaceuticals Ltd139.89-17877.69%
CORTCorcept Therapeutics Inc158.39-20228.54%